Quick Answer
Caris Life Sciences, Inc. reported Earnings Per Share Diluted of $3.22 (loss) per share for the year ending 2025.
- Caris Life Sciences, Inc. showed an increase of +69.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Caris Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Caris Life Sciences, Inc.'s Earnings Per Share Diluted has grown by 75.7%.
- Historical annual values: Fiscal year 2025: $3.22 (loss) per share | Fiscal year 2024: $10.66 (loss) per share | Fiscal year 2023: $13.24 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: